We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05135650
Recruitment Status : Suspended (Enrollment temporarily on hold for amendment submission)
First Posted : November 26, 2021
Last Update Posted : January 26, 2023
National Marrow Donor Program
Vir Biotechnology, Inc.
Information provided by (Responsible Party):
Fred Hutchinson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : January 15, 2024
Estimated Study Completion Date : January 15, 2024